Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids: Case report

RATIONALE: Castleman's disease (CD) is a rare lymphoproliferative disease. Compared to unicentric CD, multicentric Castleman disease (MCD) displays poorer prognosis and great variance to different therapies. Though chemotherapy, immunization therapy, and glucocorticoids have been used in the tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Sisi, Zhong, Zhaodong, Li, Xiang, Wang, Hong Xiang, Wang, Li, Zhang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6867793/
https://www.ncbi.nlm.nih.gov/pubmed/31725610
http://dx.doi.org/10.1097/MD.0000000000017681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6867793/
https://www.ncbi.nlm.nih.gov/pubmed/31725610
http://dx.doi.org/10.1097/MD.0000000000017681

Ejemplares similares